Page 50 - Protein Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Good morning, and welcome to the Bio-Techne earnings conference call for the Second Quarter of Fiscal Year 2021. [Operator Instructions] I would now like to turn the call over to David Clair, Bio-Techne's Senior Director, Investor Relations and Corporate Development. David Clair -- Senior Director, Investor Relations & Corporate Development Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement. Some ...

Meriden-based Protein Sciences’ parent company to make Pfizer vaccine Meriden-based Protein Sciences’ parent company to make Pfizer vaccine Clem Lewin, associate vice president of research and development strategy at Sanofi, speaks to the media as Lt. Gov. Susan Bysiewicz, left, Connecticut Gov. Ned Lamont, second from right, and Mireli Fino, site head at Protein Sciences, listen during visit by the governor to Protein Sciences, Thursday, March 12, 2020, in Meriden. (AP Photo/Jessica Hill) January 27, 2021 06:14PM By Mary Ellen Godin, Record-Journal staff Sanofi...

Weekly allotment of COVID vaccine is set to increase from 46,000 to about 54,000 doses Author: Matt Caron Updated: 4:36 PM EST January 27, 2021 MERIDEN, Conn. — The Biden administration will order 200-million more doses of the COVID vaccines from Pfizer and Moderna. It's in an effort to reach their goal of 100-million doses in 100 days. But those doses won’t just magically appear.  At Protein Sciences in Meriden, they’ve been developing two of their own COVID vaccines, but last month, they hit a snag. The concentration of their formula wasn't strong enou...

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, February 2, 2021, at...

(1) Technavio estimates the global liquid biopsy market is expected to grow by USD 4.02 billion, progressing at a CAGR of almost 38% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201214005597/en/ Technavio has announced its latest market research report titled Global Liquid Biopsy Market 2020-2024 (Graphic: Business Wire) The market is driven by increasing fundin...